FEB 06, 2019 11:03 AM PST

Researchers Link Cardiometabolic Disease and a Protein Called Clusterin

WRITTEN BY: Carmen Leitch

Cardiometabolic syndrome (CMS) refers to a range of problems with the kidneys, cardiovascular system, metabolism, and inflammation, and it increases the risk of stroke, diabetes, and heart disease. Now researchers have linked a protein called clusterin to this disorder, which can involve excess body fat, high blood sugar, high blood pressure, abnormal cholesterol and is exacerbated by sedentary lifestyles and smoking. The study, which included human participants and a mouse model, has been reported in the journal Diabetes Care.

"Our goal was to discover new factors produced by the cells in fat tissue that have an impact on cardiometabolic disease. In particular, we wanted to identify those important to maintaining the framework of fat tissue, called the extracellular matrix, which becomes dysfunctional in obesity," explained the first author of the report Dr. David Bradley, an assistant professor in the Division of Endocrinology, Diabetes and Metabolism at The Ohio State University Wexner Medical Center.

Clusterin is an extracellular matrix protein, and fat cells in obese patients make too much of it. The protein is strongly linked to insulin resistance and has been connected to an increase in the risk of cardiovascular disease risk, high blood pressure, harmful cholesterol levels, fatty liver disease, and mortality. Insulin resistance can lead to type 2 diabetes, while obesity causes a range of health problems.

The researchers assessed gene expression, took measurements of biomarkers and performed correlation analysis on 54 obese patients and 18 that were lean, who were all undergoing elective surgery. Additional work was done in cultured cells and a mouse model that is prone to obesity-related complications. The team showed that clusterin derived from fat correlates with cardiovascular disease risk.

"This collaborative research is shedding new light on the importance of clusterin on cardiometabolic syndrome, which may eventually lead to developing new treatments for this life-threatening combination of diabetes, high blood pressure and obesity," said Dr. K. Craig Kent, dean of the Ohio State College of Medicine. 

"Previously this protein clusterin has been mostly studied for its role in neurodegenerative diseases such as Alzheimer's but it now appears to have a broader role in human physiology and disease," he added.

"This study shows the hypothesis generation power of emerging systems biology approaches in discovering novel targets and mechanisms on complex diseases such as CMS. The clusterin protein is a key component of the extracellular matrix, so this work opens up a new vista to understand the role of clusterin in inter-cellular crosstalk of tissue microenvironments of various diseases, including diabetes, cancer, and neurodegeneration," said the co-corresponding author, Dr. Stephen T. C. Wong, professor and chair of the Department of Systems Medicine and Bioengineering at Houston Methodist.


Sources: AAAS/Eurekalert! Via Ohio State University Wexner Medical Center, Diabetes Care

About the Author
  • Experienced research scientist and technical expert with authorships on 28 peer-reviewed publications, traveler to over 60 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
DEC 13, 2018
Genetics & Genomics
DEC 13, 2018
Insights Into the Mechanisms Underlying Anxiety
Up to 40 million Americans have an anxiety disorder in any given year, and it's thought that only about a third get treatment....
JAN 06, 2019
Videos
JAN 06, 2019
Developing Tissue-engineered Discs to Treat Bad Backs
As we age, the discs of padding that sit between our vertebrae begin to wear down, which is a common cause of back pain....
JAN 07, 2019
Genetics & Genomics
JAN 07, 2019
Glioblastoma Affects Men Differently Than Women
It's been established that men have slightly higher rates of cancer and a greater likelihood of dying from the disease. But why?...
JAN 07, 2019
Cell & Molecular Biology
JAN 07, 2019
Researchers Develop an Experimental Therapy for Triple-negative Breast Cancer
Between 12 and 17% of all breast cancer cases are triple-negative, a highly aggressive type with few therapeutic options....
JAN 16, 2019
Cell & Molecular Biology
JAN 16, 2019
Molecule Can Reduce the Growth & Spread of Breast Cancer
A protein called Nischarin can help stop breast cancer from growing and metastasizing....
FEB 05, 2019
Microbiology
FEB 05, 2019
Time-lapse Microscopy Reveals More About the Microbial Life Cycle
Bacteria have to be able to defend themselves from other microbes, making some microbes valuable producers of antibiotics....
Loading Comments...